The results, published in Journal of Heart and Lung Transplantation, implanted the Jarvik 2015 Ventricular Assist Device in seven children ages 8 months to 7 years. The children spent months using the device before their transplant and were able to participate in normal play activities. All the children survived, though one child — whose heart recovered and thus did not require a transplant — had a stroke on the 53rd day following device implantation.
The device is not FDA approved.
Leave a Reply